UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

trans-Activation and Repression Properties of the Novel Nonsteroid Glucocorticoid Receptor Ligand 2,5-Dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and Its Four Stereoisomers

Molecular pharmacology, 2002-08, Vol.62 (2), p.297

2002

Volltextzugriff (PDF)

Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: Side chain exploration

Bioorganic & medicinal chemistry letters, 2006-04, Vol.16 (7), p.1864-1868

2006

Volltextzugriff (PDF)

Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residues

Journal of medicinal chemistry, 1992-05, Vol.35 (11), p.2007-2014

1992

Volltextzugriff (PDF)

Substituted Hexahydrobenzo[f]thieno[c]quinolines as Dopamine D1-Selective Agonists: Synthesis and Biological Evaluation in Vitro and in Vivo

Journal of medicinal chemistry, 1997-05, Vol.40 (11), p.1585-1599

1997

Volltextzugriff (PDF)

trans-2,6-, 3,6- and 4,6-Diaza-5,6,6a,7,8,12b-hexahydrobenzo[ C]phenanthrene-10,11-diols as dopamine agonists

Bioorganic & medicinal chemistry letters, 1999-05, Vol.9 (10), p.1341-1346

1999

Volltextzugriff (PDF)

Minor Structural Differences in Boc-CCK-4 Derivatives Dictate Affinity and Selectivity for CCK-A and CCK-B Receptors

Journal of medicinal chemistry, 1997-03, Vol.40 (7), p.1169-1172

1997

Volltextzugriff (PDF)

Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization

Molecular pharmacology, 1993-12, Vol.44 (6), p.1113-1118

1993

Volltextzugriff (PDF)

Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-A receptor agonists

Journal of medicinal chemistry, 1991-09, Vol.34 (9), p.2837-2842

1991

Volltextzugriff (PDF)

Excitatory effects of cholecystokinin octapeptide on rat nodose ganglion cells in vitro

Brain research, 1991-08, Vol.556 (1), p.161-164

1991

Volltextzugriff (PDF)

Tetrapeptide CCK-A Agonists: Effect of Backbone N-Methylations on in vitro and in vivo CCK Activity

Journal of medicinal chemistry, 1994-03, Vol.37 (5), p.630-635

1994

Volltextzugriff (PDF)

Identification and characterization of type A endothelin receptors in MMQ cells

Molecular pharmacology, 1993-08, Vol.44 (2), p.285-291

1993

Volltextzugriff (PDF)

Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells

Peptides (New York, N.Y. : 1980), 1992-11, Vol.13 (6), p.1227-1232

1992

Volltextzugriff (PDF)

Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists

Journal of medicinal chemistry, 1989-04, Vol.32 (4), p.739-742

1989

Volltextzugriff (PDF)

Peripheral cholecystokinin type A receptors mediate oxytocin secretion in vivo

Regulatory peptides, 1993, Vol.43 (1), p.107-112

1993

Volltextzugriff (PDF)

Induced expression of neuronal membrane attack complex and cell death by Alzheimer's β-amyloid peptide

Brain research, 1998-06, Vol.796 (1), p.187-197

1998

Volltextzugriff (PDF)

trans-3-n-propyl-L-proline is a highly favorable, conformationally restricted replacement for methionine in the C-terminal tetrapeptide of cholecystokinin. Stereoselective synthesis of 3-allyl- and 3-n-propyl-L-proline derivatives from 4-hydroxy-L-proline

Journal of medicinal chemistry, 1991-01, Vol.34 (1), p.455-457

1991

Volltextzugriff (PDF)

Glucagon receptor antagonists for the treatment of type II diabetes: current prospects

Current opinion in investigational drugs (London, England : 2000), 2002-11, Vol.3 (11), p.1617

2002

Volltextzugriff (PDF)

(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]-phenanthrene-9,10-diol (A-86929) : a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)

Journal of medicinal chemistry, 1995-09, Vol.38 (18), p.3445-3447

1995

Volltextzugriff (PDF)

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease

The Journal of pharmacology and experimental therapeutics, 1996-01, Vol.276 (1), p.150

1996

Volltextzugriff (PDF)

trans -Activation and Repression Properties of the Novel Nonsteroid Glucocorticoid Receptor Ligand 2,5-Dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1 H -[1]benzopyrano[3,4- f ]quinoline (A276575) and Its Four Stereoisomers

Molecular pharmacology, 2002-08, Vol.62 (2), p.297-303

2002

Volltextzugriff (PDF)

Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636

The Journal of pharmacology and experimental therapeutics, 1996-03, Vol.276 (3), p.1022

1996

Volltextzugriff (PDF)

Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells

Molecular pharmacology, 1995-01, Vol.47 (1), p.131-139

1995

Volltextzugriff (PDF)

Both CCK-A and CCK-B/gastrin receptors are present on rabbit vagus nerve

American journal of physiology. Regulatory, integrative and comparative physiology, 1992-09, Vol.263 (3), p.591-R595

1992

Volltextzugriff (PDF)

Human astrocytoma U138MG cells express predominantly type-A endothelin receptor

Biochimica et biophysica acta, 1996-05, Vol.1311 (3), p.155-163

1996

Volltextzugriff (PDF)

Development of CCK-tetrapeptide analogs as potent and selective CCK-A receptor agonists

Journal of medicinal chemistry, 1990-11, Vol.33 (11), p.2950-2952

1990

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

trans-Activation and Repression Properties of the Novel Nonsteroid Glucocorticoid Receptor Ligand 2,5-Dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and Its Four Stereoisomers

Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: Side chain exploration

Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residues

Substituted Hexahydrobenzo[f]thieno[c]quinolines as Dopamine D1-Selective Agonists: Synthesis and Biological Evaluation in Vitro and in Vivo

trans-2,6-, 3,6- and 4,6-Diaza-5,6,6a,7,8,12b-hexahydrobenzo[ C]phenanthrene-10,11-diols as dopamine agonists

Minor Structural Differences in Boc-CCK-4 Derivatives Dictate Affinity and Selectivity for CCK-A and CCK-B Receptors

Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization

Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-A receptor agonists

Excitatory effects of cholecystokinin octapeptide on rat nodose ganglion cells in vitro

Tetrapeptide CCK-A Agonists: Effect of Backbone N-Methylations on in vitro and in vivo CCK Activity

Identification and characterization of type A endothelin receptors in MMQ cells

Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells

Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists

Peripheral cholecystokinin type A receptors mediate oxytocin secretion in vivo

Induced expression of neuronal membrane attack complex and cell death by Alzheimer's β-amyloid peptide

trans-3-n-propyl-L-proline is a highly favorable, conformationally restricted replacement for methionine in the C-terminal tetrapeptide of cholecystokinin. Stereoselective synthesis of 3-allyl- and 3-n-propyl-L-proline derivatives from 4-hydroxy-L-proline

Glucagon receptor antagonists for the treatment of type II diabetes: current prospects

(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]-phenanthrene-9,10-diol (A-86929) : a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease

trans -Activation and Repression Properties of the Novel Nonsteroid Glucocorticoid Receptor Ligand 2,5-Dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1 H -[1]benzopyrano[3,4- f ]quinoline (A276575) and Its Four Stereoisomers

Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636

Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells

Both CCK-A and CCK-B/gastrin receptors are present on rabbit vagus nerve

Human astrocytoma U138MG cells express predominantly type-A endothelin receptor

Development of CCK-tetrapeptide analogs as potent and selective CCK-A receptor agonists

Suchergebnisse filtern